{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:13:16Z","timestamp":1789693996330,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R42NS135834-01"],"award-info":[{"award-number":["1R42NS135834-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jmoldx.2025.03.010","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:48:56Z","timestamp":1745390936000},"page":"615-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Analytical Validation and Clinical Sensitivity of the Belay Summit Assay for the Detection of DNA Variants in Cerebrospinal Fluid of Primary and Metastatic Central Nervous System Cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"Qian","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kala F.","family":"Schilter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8267-644X","authenticated-orcid":false,"given":"Kyle M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2998-1070","authenticated-orcid":false,"given":"Jennifer N.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakshitha","family":"Jagadish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1027-4021","authenticated-orcid":false,"given":"Anthony","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4136-8634","authenticated-orcid":false,"given":"Brett A.","family":"Domagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-7820","authenticated-orcid":false,"given":"Sakshi","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baymuhammet","family":"Muhammedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2510-4151","authenticated-orcid":false,"given":"Christopher","family":"Douville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Coe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Bettegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-9993","authenticated-orcid":false,"given":"Honey V.","family":"Reddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2025.03.010_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41576-021-00338-8","article-title":"Clinical cancer genomic profiling","volume":"22","author":"Chakravarty","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/jalm\/jfad091","article-title":"Clinical utility and benefits of comprehensive genomic profiling in cancer","volume":"9","author":"Tjota","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib3","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41416-023-02446-0","article-title":"Liquid biopsy: creating opportunities in brain space","volume":"129","author":"Trivedi","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCO.0000000000001079","article-title":"Liquid biopsy in brain tumors: moving on, slowly","volume":"36","author":"Berzero","year":"2024","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/neuonc\/noz156","article-title":"The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors","volume":"21","author":"Mattox","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib6","article-title":"Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules","volume":"120","author":"Wang","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib7","article-title":"Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid","volume":"4","author":"Douville","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20040","article-title":"Detection of leptomeningeal disease using cell-free DNA from cerebrospinal fluid","volume":"4","author":"White","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ccell.2021.09.012","article-title":"Serial assessment of measurable residual disease in medulloblastoma liquid biopsies","volume":"39","author":"Liu","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jmoldx.2021.03.001","article-title":"Clinical experience of cerebrospinal fluid-based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling","volume":"23","author":"Bale","year":"2021","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/neuonc\/noac035","article-title":"Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients","volume":"24","author":"Miller","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib12","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijsu.2016.10.023","article-title":"Accuracy of conventional MRI for preoperative diagnosis of intracranial tumors: a retrospective cohort study of 762 cases","volume":"36","author":"Yan","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cncy.21502","article-title":"Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid","volume":"123","author":"Ho","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","article-title":"Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results","volume":"82","author":"Glantz","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4132\/KoreanJPathol.2013.47.6.563","article-title":"Diagnostic accuracy of cerebrospinal fluid (CSF) cytology in metastatic tumors: an analysis of consecutive CSF samples","volume":"47","author":"Bae","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.wneu.2015.05.025","article-title":"Complications following stereotactic needle biopsy of intracranial tumors","volume":"84","author":"Malone","year":"2015","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib19","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1038\/s41598-019-44622-4","article-title":"The diagnostic quality of needle brain biopsy specimens obtained with different sampling methods - experimental study","volume":"9","author":"Trojanowski","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib20","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3390\/ijms22094548","article-title":"Liquid biomarkers for improved diagnosis and classification of CNS tumors","volume":"22","author":"Bunda","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib21","first-page":"60","article-title":"Initial symptoms and diagnostic delay in children with brain tumors at a single institution in Japan","volume":"8","author":"Yamada","year":"2021","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"The UKMRC: long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/fampra\/cmv075","article-title":"Symptomatic diagnosis of cancer of the brain and central nervous system in primary care: a systematic review","volume":"32","author":"Schmidt-Hansen","year":"2015","journal-title":"Fam Pract"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib24","first-page":"227","article-title":"Delays in diagnosis for children with newly diagnosed central nervous system tumors","volume":"5","author":"Coven","year":"2018","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/neuonc\/noae267","article-title":"NCCN CNS tumor guidelines update for 2024","volume":"27","author":"Nabors","year":"2025","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","article-title":"Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists","volume":"19","author":"Jennings","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/clinchem\/hvaa164","article-title":"Generic protocols for the analytical validation of next-generation sequencing-based ctDNA assays: a joint consensus recommendation of the BloodPAC's analytical variables working group","volume":"66","author":"Godsey","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jmoldx.2025.02.009","article-title":"A comprehensive guide to achieving New York State Clinical Laboratory Evaluation Program approval for next-generation sequencing assays","volume":"27","author":"Galbo","year":"2025","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib31","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29 Suppl 1","author":"Armbruster","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/FTD.0000000000000168","article-title":"Describing assay precision-reciprocal of variance is correct, not CV percent: its use should significantly improve laboratory performance","volume":"37","author":"Jelliffe","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/NEN.0000000000000093","article-title":"PTEN mutations and activation of the PI3K\/Akt\/mTOR signaling pathway in papillary tumors of the pineal region","volume":"73","author":"Goschzik","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib34","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/curroncol28020121","article-title":"PTEN R130Q papillary tumor of the pineal region (PTPR) with chromosome 10 loss successfully treated with everolimus: a case report","volume":"28","author":"Assi","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11060-024-04645-y","article-title":"Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors","volume":"168","author":"Ronsley","year":"2024","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100281","article-title":"Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic CNS tumors","volume":"6","author":"Charifa","year":"2024","journal-title":"J Liquid Biopsy"},{"key":"10.1016\/j.jmoldx.2025.03.010_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ijlh.13869","article-title":"Technological features of blast identification in the cerebrospinal fluid: a systematic review of flow cytometry and laboratory haematology methods","volume":"44 Suppl 1","author":"Frater","year":"2022","journal-title":"Int J Lab Hematol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T10:28:03Z","timestamp":1750760883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157825000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1525157825000923"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.03.010","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical Validation and Clinical Sensitivity of the Belay Summit Assay for the Detection of DNA Variants in Cerebrospinal Fluid of Primary and Metastatic Central Nervous System Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}